Published in J Allergy Clin Immunol on June 12, 2010
Oral immunotherapy for treatment of egg allergy in children. N Engl J Med (2012) 5.19
Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial. Lancet (2014) 4.36
Peanut oral immunotherapy is not ready for clinical use. J Allergy Clin Immunol (2010) 3.49
A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response. J Allergy Clin Immunol (2011) 2.77
Future therapies for food allergies. J Allergy Clin Immunol (2011) 2.04
Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization. J Allergy Clin Immunol (2011) 1.93
Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapy. J Allergy Clin Immunol (2013) 1.73
Safety and feasibility of oral immunotherapy to multiple allergens for food allergy. Allergy Asthma Clin Immunol (2014) 1.61
Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens. J Allergy Clin Immunol (2012) 1.56
Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3). J Allergy Clin Immunol (2014) 1.49
Dietary baked egg accelerates resolution of egg allergy in children. J Allergy Clin Immunol (2012) 1.26
Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial. J Allergy Clin Immunol (2013) 1.24
IgG4 inhibits peanut-induced basophil and mast cell activation in peanut-tolerant children sensitized to peanut major allergens. J Allergy Clin Immunol (2015) 1.22
Oral immunotherapy induces local protective mechanisms in the gastrointestinal mucosa. J Allergy Clin Immunol (2012) 1.19
Changes in antigen-specific T-cell number and function during oral desensitization in cow's milk allergy enabled with omalizumab. Mucosal Immunol (2012) 1.18
Ara h 1-reactive T cells in individuals with peanut allergy. J Allergy Clin Immunol (2011) 1.15
A pilot study of omalizumab to facilitate rapid oral desensitization in high-risk peanut-allergic patients. J Allergy Clin Immunol (2013) 1.11
Mechanisms of immune tolerance relevant to food allergy. J Allergy Clin Immunol (2011) 1.11
Evidence of pathway-specific basophil anergy induced by peanut oral immunotherapy in peanut-allergic children. Clin Exp Allergy (2012) 1.08
Suppression of the immunologic response to peanut during immunotherapy is often transient. J Allergy Clin Immunol (2014) 1.07
Mechanisms of allergen-specific immunotherapy. Clin Transl Allergy (2012) 1.06
Oral immunotherapy for food allergy: towards a new horizon. Allergy Asthma Immunol Res (2012) 0.98
Treatment of asthma and food allergy with herbal interventions from traditional chinese medicine. Mt Sinai J Med (2011) 0.98
A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy. J Allergy Clin Immunol (2014) 0.97
Peanut allergy and anaphylaxis. Curr Opin Immunol (2010) 0.95
Sublingual vs oral immunotherapy for food allergy: identifying the right approach. Drugs (2012) 0.92
A phase 1 study of heat/phenol-killed, E. coli-encapsulated, recombinant modified peanut proteins Ara h 1, Ara h 2, and Ara h 3 (EMP-123) for the treatment of peanut allergy. Allergy (2013) 0.90
The safety of peanut oral immunotherapy in peanut-allergic subjects in a single-center trial. Int Arch Allergy Immunol (2012) 0.88
Diagnosis and management of food allergies: new and emerging options: a systematic review. J Asthma Allergy (2014) 0.88
Single B-cell deconvolution of peanut-specific antibody responses in allergic patients. J Allergy Clin Immunol (2015) 0.87
Omalizumab facilitates rapid oral desensitization for peanut allergy. J Allergy Clin Immunol (2016) 0.86
Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial. J Allergy Clin Immunol (2015) 0.85
Anaphylaxis: a history with emphasis on food allergy. Immunol Rev (2011) 0.84
The future of food allergy therapeutics. Semin Immunopathol (2012) 0.84
Immunological mechanisms for desensitization and tolerance in food allergy. Semin Immunopathol (2012) 0.83
Emerging therapies for food allergy. J Clin Invest (2014) 0.83
Blockade of peanut allergy with a novel Ara h 2-Fcγ fusion protein in mice. J Allergy Clin Immunol (2012) 0.83
Pepsinized cashew proteins are hypoallergenic and immunogenic and provide effective immunotherapy in mice with cashew allergy. J Allergy Clin Immunol (2012) 0.82
Use of animal models to investigate major allergens associated with food allergy. J Allergy (Cairo) (2013) 0.82
Oral desensitization for food hypersensitivity. Immunol Allergy Clin North Am (2011) 0.81
Treatments for food allergy: how close are we? Immunol Res (2012) 0.80
T-cell biology in immunotherapy. Ann Allergy Asthma Immunol (2014) 0.80
Inhibition of Pim1 kinase prevents peanut allergy by enhancing Runx3 expression and suppressing T(H)2 and T(H)17 T-cell differentiation. J Allergy Clin Immunol (2012) 0.79
Advances in immunotherapy for food allergy. Discov Med (2012) 0.79
CD4-blockade can induce protection from peanut-induced anaphylaxis. Front Immunol (2011) 0.79
Food allergy diagnosis and therapy: where are we now? Immunotherapy (2013) 0.79
Oral immunotherapy for the treatment of food allergy. Hum Vaccin Immunother (2014) 0.78
Type B CpG oligodeoxynucleotides induce Th1 responses to peanut antigens: modulation of sensitization and utility in a truncated immunotherapy regimen in mice. Mol Nutr Food Res (2013) 0.77
Peanut immunotherapy. Clin Transl Allergy (2014) 0.77
Diagnosis, management, and investigational therapies for food allergies. Gastroenterology (2015) 0.77
Nonallergen-specific treatments for food allergy. Curr Opin Allergy Clin Immunol (2012) 0.77
Modulation of dendritic cell innate and adaptive immune functions by oral and sublingual immunotherapy. Clin Immunol (2014) 0.77
Sublingual (SLIT) versus oral immunotherapy (OIT) for food allergy. Curr Allergy Asthma Rep (2014) 0.77
Deciphering the black box of food allergy mechanisms. Ann Allergy Asthma Immunol (2017) 0.76
An update on immunotherapy for food allergy. Curr Opin Allergy Clin Immunol (2010) 0.76
Food allergy: immune mechanisms, diagnosis and immunotherapy. Nat Rev Immunol (2016) 0.76
A practical view of immunotherapy for food allergy. Korean J Pediatr (2016) 0.76
Safety, clinical, and immunologic efficacy of a Chinese herbal medicine (Food Allergy Herbal Formula-2) for food allergy. J Allergy Clin Immunol (2015) 0.76
Developing therapies for peanut allergy. Int Arch Allergy Immunol (2014) 0.76
Recent advances in immunotherapy and vaccine development for peanut allergy. Ther Adv Vaccines (2015) 0.75
Relationships Among Maternal Stress and Depression, Type 2 Responses, and Recurrent Wheezing at Age 3 Years in Low Income Urban Families. Am J Respir Crit Care Med (2016) 0.75
Novel baseline predictors of adverse events during oral immunotherapy in children with peanut allergy. J Allergy Clin Immunol (2016) 0.75
Anaphylaxis in children: current understanding and key issues in diagnosis and treatment. Curr Allergy Asthma Rep (2012) 0.75
Desensitization for Peanut Allergies in Children. Curr Treat Options Allergy (2016) 0.75
Oral Immunotherapy for Treatment of Immunoglobulin E-Mediated Food Allergy: The Transition to Clinical Practice. Pediatr Allergy Immunol Pulmonol (2014) 0.75
Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapy. J Allergy Clin Immunol (2016) 0.75
Peanut oral immunotherapy in adolescents: study protocol for a randomized controlled trial. Trials (2015) 0.75
Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol (2011) 12.48
Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol (2010) 5.55
Oral immunotherapy for treatment of egg allergy in children. N Engl J Med (2012) 5.19
Further fatalities caused by anaphylactic reactions to food, 2001-2006. J Allergy Clin Immunol (2007) 4.25
Food allergy. J Allergy Clin Immunol (2009) 4.05
US prevalence of self-reported peanut, tree nut, and sesame allergy: 11-year follow-up. J Allergy Clin Immunol (2010) 3.99
Clinical efficacy and immune regulation with peanut oral immunotherapy. J Allergy Clin Immunol (2009) 3.91
Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol (2002) 3.71
Prevalence of peanut and tree nut allergy in the United States determined by means of a random digit dial telephone survey: a 5-year follow-up study. J Allergy Clin Immunol (2003) 3.06
Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med (2003) 3.00
Guidelines for the Diagnosis and Management of Food Allergy in the United States: Summary of the NIAID-Sponsored Expert Panel Report. J Allergy Clin Immunol (2010) 2.98
Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma & Immunology-European Academy of Allergy and Clinical Immunology PRACTALL consensus report. J Allergy Clin Immunol (2012) 2.90
Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants. J Allergy Clin Immunol (2015) 2.82
Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet (2006) 2.81
9. Food allergy. J Allergy Clin Immunol (2006) 2.72
The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol (2004) 2.69
ICON: food allergy. J Allergy Clin Immunol (2012) 2.65
Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study. Pediatrics (2005) 2.56
Triggers and treatment of anaphylaxis: an analysis of 4,000 cases from Germany, Austria and Switzerland. Dtsch Arztebl Int (2014) 2.47
Immunologic changes in children with egg allergy ingesting extensively heated egg. J Allergy Clin Immunol (2008) 2.41
Early identification of atopy in the prediction of persistent asthma in children. Lancet (2008) 2.27
Tolerance to extensively heated milk in children with cow's milk allergy. J Allergy Clin Immunol (2008) 2.24
Peanut allergy: emerging concepts and approaches for an apparent epidemic. J Allergy Clin Immunol (2007) 2.22
Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol (2006) 2.09
Future therapies for food allergies. J Allergy Clin Immunol (2011) 2.04
Primary ciliary dyskinesia associated with normal axoneme ultrastructure is caused by DNAH11 mutations. Hum Mutat (2008) 2.03
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines. World Allergy Organ J (2010) 2.01
Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol (2006) 2.00
Maternal smoking in pregnancy and asthma in preschool children: a pooled analysis of eight birth cohorts. Am J Respir Crit Care Med (2012) 1.98
Maternal consumption of peanut during pregnancy is associated with peanut sensitization in atopic infants. J Allergy Clin Immunol (2010) 1.97
The natural history of milk allergy in an observational cohort. J Allergy Clin Immunol (2012) 1.96
Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma. Pediatr Infect Dis J (2006) 1.94
Preventing peanut allergy through early consumption--ready for prime time? N Engl J Med (2015) 1.91
A common variant on chromosome 11q13 is associated with atopic dermatitis. Nat Genet (2009) 1.91
Prevalence of seafood allergy in the United States determined by a random telephone survey. J Allergy Clin Immunol (2004) 1.90
Use of multiple doses of epinephrine in food-induced anaphylaxis in children. J Allergy Clin Immunol (2008) 1.86
Esophageal subepithelial fibrosis in children with eosinophilic esophagitis. J Pediatr Gastroenterol Nutr (2007) 1.85
The major glycoprotein allergen from Arachis hypogaea, Ara h 1, is a ligand of dendritic cell-specific ICAM-grabbing nonintegrin and acts as a Th2 adjuvant in vitro. J Immunol (2006) 1.79
Does the severity of atopic dermatitis correlate with serum IgE levels? Pediatr Allergy Immunol (2004) 1.79
Dietary baked milk accelerates the resolution of cow's milk allergy in children. J Allergy Clin Immunol (2011) 1.79
The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy. J Allergy Clin Immunol (2005) 1.77
Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis among European children younger than 5 years of age. Pediatrics (2009) 1.76
Acupuncture in patients with seasonal allergic rhinitis: a randomized trial. Ann Intern Med (2013) 1.76
Outcomes of office-based, open food challenges in the management of food allergy. J Allergy Clin Immunol (2011) 1.71
Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. J Allergy Clin Immunol (2012) 1.71
Body mass index trajectory classes and incident asthma in childhood: results from 8 European Birth Cohorts--a Global Allergy and Asthma European Network initiative. J Allergy Clin Immunol (2013) 1.71
Epinephrine treatment is infrequent and biphasic reactions are rare in food-induced reactions during oral food challenges in children. J Allergy Clin Immunol (2009) 1.69
Microarray immunoassay: association of clinical history, in vitro IgE function, and heterogeneity of allergenic peanut epitopes. J Allergy Clin Immunol (2004) 1.68
Food allergen sensitization in inner-city children with asthma. J Allergy Clin Immunol (2005) 1.67
Human milk-specific mucosal lymphocytes of the gastrointestinal tract display a TH2 cytokine profile. J Allergy Clin Immunol (2002) 1.67
Allergenicity assessment of genetically modified crops--what makes sense? Nat Biotechnol (2008) 1.67
A global survey of changing patterns of food allergy burden in children. World Allergy Organ J (2013) 1.66
Association of allergen-specific regulatory T cells with the onset of clinical tolerance to milk protein. J Allergy Clin Immunol (2009) 1.66
Allergen-specific basophil suppression associated with clinical tolerance in patients with milk allergy. J Allergy Clin Immunol (2009) 1.60
Food allergy: a practice parameter update-2014. J Allergy Clin Immunol (2014) 1.60
Food allergy: recent advances in pathophysiology and treatment. Annu Rev Med (2009) 1.59
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines. Pediatr Allergy Immunol (2010) 1.58
Polymorphisms and haplotypes of acid mammalian chitinase are associated with bronchial asthma. Am J Respir Crit Care Med (2005) 1.58
Risk assessment in anaphylaxis: current and future approaches. J Allergy Clin Immunol (2007) 1.57
Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens. J Allergy Clin Immunol (2012) 1.56
The Urban Environment and Childhood Asthma (URECA) birth cohort study: design, methods, and study population. BMC Pulm Med (2009) 1.53
Five-grass pollen 300IR SLIT tablets: efficacy and safety in children and adolescents. Pediatr Allergy Immunol (2010) 1.52
Anaphylaxis to diphtheria, tetanus, and pertussis vaccines among children with cow's milk allergy. J Allergy Clin Immunol (2011) 1.52
Hypoallergenicity and effects on growth and tolerance of a new amino acid-based formula with docosahexaenoic acid and arachidonic acid. J Pediatr (2008) 1.51
Allergic reactions to foods in preschool-aged children in a prospective observational food allergy study. Pediatrics (2012) 1.48
Mycobacterium tuberculosis-specific CD4+, IFNgamma+, and TNFalpha+ multifunctional memory T cells coexpress GM-CSF. Cytokine (2008) 1.46
Food protein-induced enterocolitis syndrome caused by solid food proteins. Pediatrics (2003) 1.45
Food Allergy Herbal Formula-2 silences peanut-induced anaphylaxis for a prolonged posttreatment period via IFN-gamma-producing CD8+ T cells. J Allergy Clin Immunol (2009) 1.41
Use of IgE and IgG4 epitope binding to predict the outcome of oral immunotherapy in cow's milk allergy. Pediatr Allergy Immunol (2014) 1.41
Adrenaline autoinjectors in food allergy: in for a cent, in for a euro? Pediatr Allergy Immunol (2012) 1.39
Peanut epitopes for IgE and IgG4 in peanut-sensitized children in relation to severity of peanut allergy. J Allergy Clin Immunol (2008) 1.39
Does pet ownership in infancy lead to asthma or allergy at school age? Pooled analysis of individual participant data from 11 European birth cohorts. PLoS One (2012) 1.39
Peanut allergy: Clinical and immunologic differences among patients from 3 different geographic regions. J Allergy Clin Immunol (2010) 1.37
Dipeptidyl-peptidase-IV inhibition augments postprandial lipid mobilization and oxidation in type 2 diabetic patients. J Clin Endocrinol Metab (2008) 1.36
Measurement of peptide-specific IgE as an additional tool in identifying patients with clinical reactivity to peanuts. J Allergy Clin Immunol (2003) 1.35
Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. J Allergy Clin Immunol (2002) 1.34
Life-threatening vallecular cyst in a 3-month-old infant: case report and literature review. Clin Pediatr (Phila) (2004) 1.34
IgE and IgG4 epitope mapping by microarray immunoassay reveals the diversity of immune response to the peanut allergen, Ara h 2. J Allergy Clin Immunol (2005) 1.33
Mapping of the IgE and IgG4 sequential epitopes of milk allergens with a peptide microarray-based immunoassay. J Allergy Clin Immunol (2008) 1.33
Significance of ovomucoid- and ovalbumin-specific IgE/IgG(4) ratios in egg allergy. J Allergy Clin Immunol (2012) 1.32